ResMed Inc.
Search documents
S&P/ASX 200 sees sharp rise as Australian shares reclaim 9,000 mark, banks rally on CBA results; check top gainers and losers
The Economic Times· 2026-02-11 07:30
Market Overview - The Australian Sharemarket saw a significant rally, with the S&P/ASX 200 closing at 9,014.80, up 147.40 points or 1.66%, marking a new 50-day high and the strongest close since late October 2025 [1][8] - The index has gained 0.97% over the last five days and is currently 1.10% off its 52-week high [2] Top Performers - AUSSIE BROADBAND LIMITED and AGL ENERGY LIMITED were the top performers, rising 14.79% and 11.75%, respectively [2][8] - Commonwealth Bank of Australia (CBA) rose 6.8% after reporting record first-half cash earnings, contributing to a 3.8% increase in heavyweight financials [3][8] Notable Stock Movements - Evolution Mining Limited (EVN) gained $1.300 to close at $16.280, an increase of 8.678% [6] - James Hardie Industries plc (JHX) advanced from $3.630 to $36.870, up 10.920% [8] - Domino's Pizza Enterprises shares rose 2.9% following the appointment of former McDonald's executive Andrew Gregory as CEO [9] Decliners - CSL Limited experienced the steepest decline, falling from $20.200 to $163.440, a drop of 11.000% [6][8] - Biotech major CSL slumped 18.2% to an eight-year low due to CEO Paul McKenzie's departure and a significant drop in half-year profit, impacting healthcare stocks which fell as much as 6.2% [8][9] - ResMed Inc. (RMD) slipped $1.760 to $36.790, down 4.566% [6]
Australian sharemarket crashes to lowest since April, 2025; S&P/ASX 200 falls to 11-week low; here’s how Wall Street’s drop rattled Australia
The Economic Times· 2026-02-06 07:49
Market Performance - The S&P/ASX 200 closed at 8,708.80, down 180.40 points or 2.03%, marking a new 20-day low [1] - The index has lost 1.81% over the last five days but remains virtually unchanged year-to-date [1] Top Gainers and Losers - WEB TRAVEL GROUP LIMITED and DEEP YELLOW LIMITED were the bottom performers, down 29.52% and 12.00%, respectively [1][10] - Among the top gainers, Brambles Limited rose 3.477% to $23.510, while ResMed Inc. increased by 1.228% to $37.920 [10] Sector Performance - All 11 sectors ended lower, with the Health Care sector declining by 1.16%, continuing a 2.39% decline over the last five days [7][10] - The resources index fell 4.6% for the week, its largest drop since late March, with BHP Group down 3% [8][10] Investor Sentiment - The S&P ASX volatility index increased by 21%, indicating heightened investor anxiety and expectations of market volatility [6][10] - Concerns over global growth and commodity volatility have negatively impacted investor confidence [6][10]
VEEV Stock Gains Following Latest Availability of HCP Access Data
ZACKS· 2025-03-07 18:00
Company Overview - Veeva Systems Inc. announced Veeva CRM Pulse, a data subscription service providing quarterly healthcare professional access and multichannel engagement metrics for the life sciences industry [1] - The service is currently available for Veeva's CRM customers, covering 2024 quarterly data across multiple countries including the US, Canada, and several European and Asian nations [2] - The introduction of CRM Pulse is expected to significantly enhance the Veeva Data Cloud product category, thereby boosting overall business performance [3] Financial Performance - Following the announcement of CRM Pulse, Veeva's shares increased by nearly 7.9% [4] - The company has a market capitalization of $38.34 billion and an earnings yield of 2.9%, which is favorable compared to the industry's negative yield [5] - In the last reported quarter, Veeva delivered an earnings surprise of 10.1% [5] Strategic Significance - Management believes that CRM Pulse will improve global segmentation and targeting, enhancing the value of data for commercial operations [6] - The latest availability of healthcare professional access data is seen as a significant milestone for Veeva Systems, expected to boost its business [8] Industry Prospects - The global healthcare analytics market was valued at $43.1 billion in 2023 and is projected to grow at a CAGR of 21.1% from 2024 to 2030, driven by technological advancements and the need for improved patient care [7]